10170 Church Ranch Way
Suite 100
Westminster, CO 80021
United States
720 940 2200
https://www.arcabio.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 4
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Thomas A. Keuer | President, COO & Principal Executive Officer | 374,61k | N/A | 1959 |
Mr. C. Jeffrey Dekker CPA | CFO, Treasurer & Company Secretary | 301,96k | N/A | 1965 |
ARCA biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with heart failure. It is developing Recombinant Nematode Anticoagulant Protein c2, a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. The company has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.
ARCA biopharma, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.